C. Wu et al. / Tetrahedron: Asymmetry 22 (2011) 1063–1073
1071
2-propanol = 80:20), 20 °C, 254 1 nm, 1.0 mL/min; major enantio-
mer tR = 65.7 min, minor enantiomer tR = 73.2 min. 1H NMR
(300 MHz, CD3OD) d = 4.42 (d, J = 2.47 Hz, 1H), 4.59 (d,
J = 1.65 Hz, 2H), 5.26 (d, J = 2.20 Hz, 1H), 7.71 (d, J = 8.78 Hz, 2H),
8.23 (dt, J = 8.78 Hz, 1.92 Hz, 2H) ppm. 13C NMR (75 MHz, CD3OD)
d 68.1, 74.6, 80.6, 124.1, 128.7, 148.6, 150.8, 212.6 ppm.
2-propanol = 80:20), 20 °C, 254 nm, 1.0 mL/min; major enantiomer
tR = 31.4 min, minor enantiomer tR = 38.4 min. 1H NMR (300 MHz,
CDCl3) d = 2.20 (s, 3H), 3.55 (br s, 1H), 3.69 (s, 3H), 3.54 (br s,
1H), 4.68 (d, J = 3.5 Hz, 1H), 4.82 (d, J = 3.5 Hz, 1H), 6.52(d,
J = 9.0 Hz, 2H), 6.70 (d, J = 9.0 Hz, 2H), 7.40 (d, J = 9.0 Hz, 2H),
7.57 (d, J = 9.0 Hz, 2H) ppm. 13C NMR (75 MHz, CDCl3): d = 26.6,
55.6, 60.2, 79.5, 111.9, 114.9, 115.6, 118.4, 128.3, 132.3, 139.4,
143.1, 152.9, 206.6 ppm.
4.4. General procedure for three-component anti-Mannich
reaction using 1c as a catalyst
4.4.5. (3R,4R)-3-Hydroxyl-4-(4-methoxyanilino)-4-(4-
A mixture of 1-methyl-2-pyrrolidinone (NMP, 3 mL), p-anisi-
dine (1 mmol), aldehyde (1.1 mmol), hydroxyacetone (3 mmol),
and catalyst 1c (0.2 mmol) was vigorously stirred at 0 °C (moni-
tored by TLC). Next, the mixture was diluted with AcOEt and a half
saturated ammonium chloride solution was added. The mixture
was extracted with AcOEt (three or four times). The combined or-
ganic layers were washed with brine, dried over MgSO4, concen-
trated in vacuo, and purified by flash column chromatography
(hexanes/ethyl acetate) to afford the desired Mannich addition
products 3a–n.
fluorophenyl) butan-2-one 3e11e
Yield 279.1 mg (0.92 mmol, 92%), anti:syn = 1.3:1, enantiomeric
excess: 94% of anti diastereomer; Enantiomeric excess was deter-
mined by HPLC with a Chiralpak AD-H column (hexane/2-propa-
nol = 85:15), 20 °C, 254 nm, 1.0 mL/min; major enantiomer
tR = 20.4 min, minor enantiomer tR = 15.3 min. 1H NMR (300 MHz,
CDCl3) d = 2.09 (s, 3H), 3.62 (s, 3H), 4.31 (d, J = 2.5 Hz, 1H), 4.80
(d, J = 2.5 Hz, 1H), 6.39–6.41 (m, 1H), 6.48–6.50 (m, 1H), 6.60–
6.65 (m, 2H), 6.84–6.97 (m, 2H), 7.18–7.19 (m, 1H), 7.21–7.27
(m, 1H) ppm. 13C NMR (75 Hz, CDCl3) d = 25.2, 55.6, 58.6, 80.7,
114.9, 115.3, 115.4, 115.6, 128.7, 128.8, 140.0, 152.6, 207.4 ppm.
4.4.1. (3R,4R)-3-Hydroxy-4-(p-methoxyphenyamino)-4-(p-
nitrophenyl) butan-2-one 3a12b
4.4.6. (3R,4R)-3-Hydroxyl-4-(4-methoxyanilino)-4-(4-
Yield 303.9 mg (0.92 mmol, 92%), anti:syn = 11.5:1, enantio-
meric excess: 98% of anti diastereomer; Enantiomeric excess was
determined by HPLC with a Chiralpak AD-H column (hexane/2-
propanol = 80:20), 20 °C, 254 nm, 1.0 mL/min; major enantiomer
tR = 28.0 min, minor enantiomer tR = 22.8 min. 1H NMR (300 MHz,
CDCl3) d = 2.23 (s, 3H), 3.55 (br s, 1H), 3.69 (s, 3H), 4.56 (br s,
1H), 4.71 (d, J = 3.5 Hz, 1H), 4.88 (d, J = 3.5 Hz, 1H), 6.53 (d,
J = 9.0 Hz, 2H), 6.70 (d, J = 9.0 Hz, 2H), 7.46 (d, J = 9.0 Hz, 2H),
8.13 (d, J = 9.0 Hz, 2H) ppm. 13C NMR (75 MHz, CDCl3): d = 26.6,
55.6, 60.1, 79.5, 114.9, 115.6, 123.7, 128.5, 139.4, 145.1, 147.6,
153.0, 206.4 ppm.
chlorophenyl) butan-2-one 3f12b
Yield 287.8 mg (0.90 mmol, 90%), anti:syn = 4:1, enantiomeric
excess: 96% of anti diastereomer; Enantiomeric excess was deter-
mined by HPLC with a Chiralpak AD-H column (hexane/2-propa-
nol = 90:10), 20 °C, 254 nm, 1.0 mL/min; major enantiomer
tR = 30.3 min, minor enantiomer tR = 46.8 min. 1H NMR (300 MHz,
CDCl3) d = 2.15 (s, 3H), 3.54 (br s, 1H), 3.69 (s, 3H), 3.54 (br s,
1H), 4.64 (d, J = 3.5 Hz, 1H), 4.75 (d, J = 3.5 Hz, 1H), 6.54 (d,
J = 9.0 Hz, 2H), 6.70 (d, J = 9.0 Hz, 2H), 7.21–7.26 (m, 4H) ppm.
13C NMR (75 MHz, CDCl3): d = 26.6, 55.6, 59.9, 79.6, 114.8, 115.6,
128.7, 128.8, 133.8, 135.9, 139.9, 152.7, 207.0 ppm.
4.4.2. (3R,4R)-3-Hydroxyl-4-(4-methoxyanilino)-4-(3-
nitrophenyl) butan-2-one 3b11e
4.4.7. (3R,4R)-3-Hydroxyl-4-(4-methoxyanilino)-4-(2-
chlorophenyl) butan-2-one 3g11e
Yield 307.2 mg (0.93 mmol, 93%), anti:syn = 4:1, enantiomeric
excess: 90% of anti diastereomer; Enantiomeric excess was deter-
mined by HPLC with a Chiralpak AD-H column (hexane/2-propa-
nol = 90:10), 20 °C, 254 nm, 1.0 mL/min; major enantiomer
tR = 23.9 min, minor enantiomer tR = 19.6 min. 1H NMR (300 Hz,
CD3OD) d = 2.30 (s, 3H), 3.60 (s, 3H), 4.36 (d, J = 2.2 Hz, 1H), 4.95
(d, J = 2.2 Hz, 1H), 6.41 (d, J = 9.0 Hz, 2H), 6.61 (d, J = 9.0 Hz, 1H),
7.44–7.41 (m, 1H), 7.63 (d, J = 8.2 Hz, 1H), 8.04 (d, J = 8.2 Hz, 1H),
8.20 (s, 2H) ppm. 13C NMR (75 Hz, CD3OD): d = 27.2, 75.1, 82.6,
114.5, 128.8, 129.4, 134.7, 160.6, 212.1 ppm.
Yield 278.2 mg (0.87 mmol, 87%), anti:syn = 8:1, enantiomeric
excess: 97% of anti diastereomer; Enantiomeric excess was deter-
mined by HPLC with a Chiralpak AD-H column (hexane/2-propa-
nol = 90:10), 20 °C, 254 nm, 1.0 mL/min; major enantiomer
tR = 23.7 min, minor enantiomer tR = 21.8 min. 1H NMR (300 MHz,
CDCl3) d = 2.28 (s, 3H), 3.67 (s, 3H), 4.40 (d, J = 2.4 Hz, 1H), 4.86
(d, J = 2.4 Hz, 1H), 6.49–6.51 (m, 1H), 6.57–6.58 (m, 1H), 6.66–
6.73 (m, 2H), 7.07–7.09 (m, 1H), 7.13–7.17 (m, 2H), 7.21–7.27
(m, 1H) ppm. 13C NMR (75 MHz, CDCl3): d = 24.7, 54.9, 55.6, 78.1,
114.8, 114.9, 127.2, 128.7, 128.8, 129.6, 132.8, 136.3, 139.5,
152.5, 207.1 ppm.
4.4.3. (3R,4R)-3-Hydroxyl-4-(4-methoxyanilino)-4-(2-
nitrophenyl) butan-2-one 3c11e
4.4.8. (3R,4R)-3-Hydroxyl-4-(4-methoxyanilino)-4-(4-
bromophenyl) butan-2-one 3h12b
Yield 397.3 mg (0.90 mmol, 90%), anti:syn = 6:1, enantiomeric
excess: 91% of anti diastereomer; Enantiomeric excess was deter-
mined by HPLC with a Chiralpak AD-H column (hexane/2-propa-
nol = 80:20), 20 °C, 254 nm, 1.0 mL/min; major enantiomer
tR = 25.3 min, minor enantiomer tR = 14.5 min. 1H NMR (300 MHz,
CDCl3) d = 2.44 (s, 3H), 3.67 (s, 3H), 4.64 (d, J = 1.1 Hz, 1H), 5.80 (d,
J = 1.1 Hz, 1H), 6.41 (d, J = 8.9 Hz, 2H), 6.67 (d, J = 8.9 Hz, 2H), 7.41–
7.45 (m, 1H), 7.54–7.59 (m, 2H), 8.09 (d, J = 8.3 Hz, 1H) ppm. 13C
NMR (75 Hz, CDCl3) d = 24.6, 53.7, 55.6, 78.6, 114.8, 115.0, 125.3,
128.5, 129.8, 133.7, 135.8, 139.0, 148.9, 152.7, 207.1 ppm.
Yield 327.8 mg (0.90 mmol, 90%), anti:syn = 9:1, enantiomeric
excess: 98% of anti diastereomer; Enantiomeric excess was deter-
mined by HPLC with a Chiralpak AD-H column (hexane/2-propa-
nol = 90:10), 20 °C, 254 nm, 1.0 mL/min; major enantiomer
tR = 30.5 min, minor enantiomer tR = 27.3 min. 1H NMR (300 MHz,
CDCl3) d = 2.26 (s, 3H), 3.61(s, 3H), 4.32 (d, J = 2.3 Hz, 1H), 4.79
(d, J = 2.3 Hz, 1H), 6.40 (d, J = 8.9 Hz, 2H), 6.61 (d, J = 8.9 Hz, 2H),
7.17 (d, J = 8.4 Hz,2H), 7.39 (d, J = 8.4 Hz, 2H) ppm. 13C NMR
(75 MHz, CDCl3): d = 26.7, 55.6, 60.0, 79.6, 114.8, 115.6, 122.0,
129.1, 131.7, 136.4, 139.8, 152.7, 206.9 ppm.
4.4.4. (3R,4R)-3-Hydroxyl-4-(4-methoxyanilino)-4-(4-
cyanophenyl) butan-2-one 3d12b
Yield 282.4 mg (0.91 mmol, 91%), anti:syn = 4:1, enantiomeric
excess: >99% of anti diastereomer; Enantiomeric excess was
determined by HPLC with a Chiralpak AD-H column (hexane/
4.4.9. (3R,4R)-3-Hydroxy-4-(p-methoxyphenyamino)-4-
phenylbutan-2-one 3i11e
Yield 214.0 mg (0.75 mmol, 75%), anti:syn = 1:1, enantiomeric
excess: 70% of anti diastereomer; Enantiomeric excess was